BTS Research coming into the picture is one of the single best developments so far for reason they're your classic Contract Research Organization (CRO) I spoke of in a previous post about Protheragen. Apparently, BTS is picking up where Protheragen left off?
Fundamentally, BTS is the catalysts for systematically moving toward clinical trials with FDA approval for commercialization. However, with this move, I discern something happened with the arrangements BioClonetics had with Protheragen for reason BTS does the exact same thing as Protheragen.
Next up multi-Source funding will likely come into place soon as well as the appearance of a Bigpharma partner both of which combined will definitely send the PPS Northward!
IMO...Spring (March-April) will be a major "milestone" transitional period for this company with everything coming into place as it should.
It will be absolutely "transformational" and with this the PPS should be between $1-$2 keeping in mind that the STOP SIGN would be long gone by then.
News 
Market Data 
Discover 
